Pascale Boulet is an IP and pharmaceutical policy advisor for Drugs for Neglected Diseases (DNDi). Pascale coordinates policy research and analysis on intellectual property (IP) management, regulatory barriers, innovative financing and incentive mechanisms for neglected diseases R&D. Previously, Pascale worked with Médecins Sans Frontières as senior legal adviser of MSF Campaign for Access to Essential Medicines and with the World Health Organization (WHO) as technical officer in the Essential Drugs and other Medicines Department.
Registering New Drugs for Low-Income Countries: The African Challenge. Moran M, Strub-Wourgaft N, Guzman J, Boulet P, Wu L, Pecoul B. PLoS Medicine, 2011 February, Vol. 8, Issue 2, e1000411. Regional Assessment of Patent and Related Issues and Access to Medicines. CARICOM member states and the Dominican Republic. HERA, 2009 (undertook Belize and Haiti IP case studies). Determining the Patent Status of Essential Medicines in Developing Countries. MSF/UNAIDS/WHO, 2004. Drug Patents under the Spotlight – Sharing practical knowledge about pharmaceutical patents. Médecins Sans Frontières, May 2003. Patent situation of HIV/AIDS-related drugs in 80 countries. UNAIDS/WHO, January 2000